FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jeffrey Ross

Research Profile

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Genes & Molecular Sequences

Genes, erbB-2

Co-author Network

Publications

TOP 3
Jessica Kumar; Xiaojiang Li; Karl Robstad; Jeffrey S Ross; Barbara Weiser; Harold Burger; Douglas Fish; David Jones; Vishnu Chaturvedi
Successful surgical intervention for the management of endocarditis due to multidrug resistant Candida parapsilosis: case report and literature review.
Michael W Kilpatrick; William A Marganski; Merrill S Ross; Christine E Sheehan; Triantafyllos Tafas; Jeffrey S Ross
Determination of HER2 gene status by fully automated fluorescence microscopy.
Jeffrey S Ross
Point: Fluorescence in situ hybridization is the preferred approach over immunohistochemistry for determining HER2 status.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jeffrey Ross (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Jessica Kumar; Xiaojiang Li; Karl Robstad; Jeffrey S Ross; Barbara Weiser; Harold Burger; Douglas Fish; David Jones; Vishnu Chaturvedi
Successful surgical intervention for the management of endocarditis due to multidrug resistant Candida parapsilosis: case report and literature review.
Mycopathologia 2011;172(4):287-92.
2011: Michael W Kilpatrick; William A Marganski; Merrill S Ross; Christine E Sheehan; Triantafyllos Tafas; Jeffrey S Ross
Determination of HER2 gene status by fully automated fluorescence microscopy.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 2011;33(4):205-10.
2011: Jeffrey S Ross
Point: Fluorescence in situ hybridization is the preferred approach over immunohistochemistry for determining HER2 status.
Clinical chemistry 2011;57(7):980-2.
2011: Konstantinos Linos; Jeffrey S Ross; Andrzej Slominski; John Carlson
Melanoma update: diagnostic and prognostic factors that can effectively shape and personalize management.
Biomarkers in medicine 2011;5(3):333-60.
2011: Jeffrey S Ross
Biomarker-based selection of therapy for colorectal cancer.
Biomarkers in medicine 2011;5(3):319-32.
2011: Jeffrey S Ross
Update on HER2 testing for breast and upper gastrointestinal tract cancers.
Biomarkers in medicine 2011;5(3):307-18.
2011: Jeffrey S Ross
Cancer biomarkers, companion diagnostics and personalized oncology.
Biomarkers in medicine 2011;5(3):277-9.
2010: Jeffrey S Ross
Measuring circulating miRNAs: the new "PSA" for Breast Cancer?
The oncologist 2010;15(7):656.
2010: Jeffrey S Ross
Biomarker update for breast, colorectal and non-small cell lung cancer.
Drug news & perspectives 2010;23(1):82-8.
2009: Lajos Pusztai; Jong-Hyeon Jeong; Yun Gong; Jeffrey S Ross; Chungyeul Kim; Soonmyung Paik; Roman Rouzier; Fabrice Andre; Gabriel N Hortobagyi; Norman Wolmark; W Fraser Symmans
Evaluation of microtubule-associated protein-Tau expression as a prognostic and predictive marker in the NSABP-B 28 randomized clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4287-92.
2009: Jeffrey S Ross
Biomarkers and drug development 2009.
Expert opinion on medical diagnostics 2009;3(5):471-8.
2009: Jeffrey S Ross; Elzbieta A Slodkowska
Circulating and disseminated tumor cells in the management of breast cancer.
American journal of clinical pathology 2009;132(2):237-45.
2009: Elzbieta A Slodkowska; Jeffrey S Ross
MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients.
Expert review of molecular diagnostics 2009;9(5):417-22.
2009: Jeffrey S Ross
Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
Advances in anatomic pathology 2009;16(4):204-15.
2009: Ceshi Chen; Zhongmei Zhou; Christine E Sheehan; Elzbieta Slodkowska; Christopher B Sheehan; Ann Boguniewicz; Jeffrey S Ross
Overexpression of WWP1 is associated with the estrogen receptor and insulin-like growth factor receptor 1 in breast carcinoma.
International journal of cancer. Journal international du cancer 2009;124(12):2829-36.
2009: Jeffrey S Ross; Elzbieta A Slodkowska; W Fraser Symmans; Lajos Pusztai; Peter M Ravdin; Gabriel N Hortobagyi
The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.
The oncologist 2009;14(4):320-68.
2009: Jeffrey S Ross
The newest stage in the evolution of drug development.
Drug news & perspectives 2009;22(1):59.
2009: Song Lu; Tien Anh Tran; David M Jones; Dale R Meyer; Jeffrey S Ross; Hugh A Fisher; John Carlson
Localized lymphedema (elephantiasis): a case series and review of the literature.
Journal of cutaneous pathology 2009;36(1):1-20.
2008: Jeffrey S Ross; Christos Hatzis; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobágyi
Commercialized multigene predictors of clinical outcome for breast cancer.
The oncologist 2008;13(5):477-93.
2007: Jeffrey S Ross; John Carlson; Graham Brock
miRNA: the new gene silencer.
American journal of clinical pathology 2007;128(5):830-6.
2007: Jeffrey S Ross
The androgen receptor in prostate cancer: therapy target in search of an integrated diagnostic test.
Advances in anatomic pathology 2007;14(5):353-7.
2007: Pankaj Bhargava; Bhaskar V S Kallakury; Jeffrey S Ross; Norio Azumi; Adam Bagg
CD79a is heterogeneously expressed in neoplastic and normal myeloid precursors and megakaryocytes in an antibody clone-dependent manner.
American journal of clinical pathology 2007;128(2):306-13.
2007: Ceshi Chen; Zhongmei Zhou; Jeffrey S Ross; Wei Zhou; Jin-Tang Dong
The amplified WWP1 gene is a potential molecular target in breast cancer.
International journal of cancer. Journal international du cancer 2007;121(1):80-87.
2007: Jeffrey S Ross; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Standardizing slide-based assays in breast cancer: hormone receptors, HER2, and sentinel lymph nodes.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(10):2831-5.
2007: Gregory M Sheehan; Bhaskar V S Kallakury; Christine E Sheehan; Hugh A G Fisher; Ronald P Kaufman; Jeffrey S Ross
Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas.
Human pathology 2007;38(4):564-9.
2006: Kenneth R Hess; Keith Anderson; W Fraser Symmans; Vicente Valero; Nuhad Ibrahim; Jaime A Mejia, M.D.; Daniel J Booser; Richard L Theriault; Aman U Buzdar; Peter J Dempsey; Roman Rouzier; Nour Sneige; Jeffrey S Ross; Tatiana Vidaurre; Henry L Gómez; Gabriel N Hortobagyi; Lajos Pusztai
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(26):4236-44.
2005: Jeffrey S Ross; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Pharmacogenomics and clinical biomarkers in drug discovery and development.
American journal of clinical pathology 2005;124 Suppl():S29-41.
2005: Jeffrey S Ross; Karen E Gray; Iain J Webb; Gary S Gray; Mark Rolfe; David P Schenkein; David M Nanus; Mathew I Millowsky; Neil H Bander
Antibody-based therapeutics: focus on prostate cancer.
Cancer metastasis reviews 2005;24(4):521-37.
2005: W Fraser Symmans; Derek J Fiterman; S K Anderson; Mark Ayers; Roman Rouzier; Valerie Dunmire; James Stec; Vicente Valero; Nour Sneige; Constance T Albarracin; Yun Wu; Jeffrey S Ross; Peter Wagner; Richard L Theriault; Banu Arun; Henry M Kuerer; Kenneth R Hess; Wei Zhang; Gabriel N Hortobagyi; Lajos Pusztai
A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding.
Endocrine-related cancer 2005;12(4):1059-69.
2005: Gregory M Sheehan; Bhaskar V S Kallakury; Christine E Sheehan; Hugh A G Fisher; Ronald P Kaufman; Jeffrey S Ross
Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas.
Human pathology 2005;36(11):1204-9.
2005: Roman Rouzier; Charles M Perou; W Fraser Symmans; Nuhad Ibrahim; Massimo Cristofanilli; Keith Anderson; Kenneth R Hess; James Stec; Mark Ayers; Peter Wagner; Paolo Morandi; Chang Fan; Islam Rabiul; Jeffrey S Ross; Gabriel N Hortobagyi; Lajos Pusztai
Breast cancer molecular subtypes respond differently to preoperative chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(16):5678-85.
2005: James Stec; Jing Wang; Kevin R Coombes; Mark Ayers; Sebastian Hoersch; David L Gold; Jeffrey S Ross; Kenneth R Hess; Stephen Tirrell; Gerald P Linette; Gabriel N Hortobagyi; W Fraser Symmans; Lajos Pusztai
Comparison of the predictive accuracy of DNA array-based multigene classifiers across cDNA arrays and Affymetrix GeneChips.
The Journal of molecular diagnostics : JMD 2005;7(3):357-67.
2005: Roman Rouzier; Radhika Rajan; Peter Wagner; Kenneth R Hess; David L Gold; James Stec; Mark Ayers; Jeffrey S Ross; Peter Zhang; Thomas Buchholz; Henry M Kuerer; Marjorie Green; Banu Arun; Gabriel N Hortobagyi; W Fraser Symmans; Lajos Pusztai
Microtubule-associated protein tau: a marker of paclitaxel sensitivity in breast cancer.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(23):8315-20.
2005: Lynn C Hartmann; Karen H Lu; Gerald P Linette; William A Cliby; Kimberly R Kalli; David M Gershenson; Robert C Bast; James Stec; Natalia Iartchouk; David I Smith; Jeffrey S Ross; Sebastian Hoersch; Viji Shridhar; James Lillie; Scott H Kaufmann; Edwin A Clark; Andrew I Damokosh
Gene expression profiles predict early relapse in ovarian cancer after platinum-paclitaxel chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2149-55.
2005: Jeffrey S Ross; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Breast cancer biomarkers.
Advances in clinical chemistry 2005;40():99-125.
2004: Jeffrey S Ross; David P Schenkein; Robert Pietrusko; Mark Rolfe; Gerald P Linette; James Stec; Nancy Stagliano; Geoffrey S Ginsburg; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Targeted therapies for cancer 2004.
American journal of clinical pathology 2004;122(4):598-609.
2004: Jeffrey S Ross; David P Schenkein; Oscar Kashala; Gerald P Linette; James Stec; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Pharmacogenomics.
Advances in anatomic pathology 2004;11(4):211-20.
2004: Shahgul Anwar; Robert A Ambros; Timothy A Jennings; Jeffrey S Ross; Anton Beza; Badar M Mian; Tipu Nazeer
Expression of cysteine protease protein 32 in prostatic adenocarcinoma correlates with tumor grade.
Archives of pathology & laboratory medicine 2004;128(6):649-52.
2004: Jeffrey S Ross; Bhaskar V S Kallakury; Christine E Sheehan; Hugh A G Fisher; Ronald P Kaufman; Prabhjot Kaur; Karen Gray; Bradley Stringer
Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immunoreactivity with disease recurrence.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2466-72.
2004: Jeffrey S Ross; Jonathan A Fletcher; Kenneth J Bloom; Gerald P Linette; James Stec; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
Targeted therapy in breast cancer: the HER-2/neu gene and protein.
Molecular & cellular proteomics : MCP 2004;3(4):379-98.
2004: Leos Kren; Jan Brazdil; Marketa Hermanova; Viktor N Goncharuk; Bhaskar V S Kallakury; Prabhjot Kaur; Jeffrey S Ross
Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2004;12(1):44-9.
2004: Jeffrey S Ross; Gerald P Linette; James Stec; Edward Clark; Mark Ayers; Nick Leschly; W Fraser Symmans; Gabriel N Hortobagyi; Lajos Pusztai
Breast cancer biomarkers and molecular medicine: part II.
Expert review of molecular diagnostics 2004;4(2):169-88.
2004: Viktor N Goncharuk; Arthur Del Rosario; Leos Kren; Shahgul Anwar; Christine E Sheehan; John Carlson; Jeffrey S Ross
Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
Annals of diagnostic pathology 2004;8(1):6-16.
2004: Prabhjot Kaur; Bhaskar S V Kallakury; Christine E Sheehan; Hugh A G Fisher; Ronald P Kaufman; Jeffrey S Ross
Survivin and Bcl-2 expression in prostatic adenocarcinomas.
Archives of pathology & laboratory medicine 2004;128(1):39-43.
2003: Jeffrey S Ross; Christine E Sheehan; Hugh A G Fisher; Ronald P Kaufman; Prabhjot Kaur; Karen Gray; Iain Webb; Gary S Gray; Rebecca Mosher; Bhaskar V S Kallakury
Correlation of primary tumor prostate-specific membrane antigen expression with disease recurrence in prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(17):6357-62.
2003: John Carlson; Andrzej Slominski; Gerald P Linette; Judith Mysliborski; Jerome Hill; Martin C Mihm; Jeffrey S Ross
Malignant melanoma 2003: predisposition, diagnosis, prognosis, and staging.
American journal of clinical pathology 2003;120 Suppl():S101-27.
2003: Jeffrey S Ross; Timothy A Jennings; Tipu Nazeer; Christine E Sheehan; Hugh A G Fisher; Ronald A Kauffman; Shahgul Anwar; Bhaskar V S Kallakury
Prognostic factors in prostate cancer.
American journal of clinical pathology 2003;120 Suppl():S85-100.
2003: Jeffrey S Ross; Gerald P Linette; James Stec; Merrill S Ross; Shahgul Anwar; Ann Boguniewicz
DNA ploidy and cell cycle analysis in breast cancer.
American journal of clinical pathology 2003;120 Suppl():S72-84.
2003: Jeffrey S Ross; Jonathan A Fletcher; Kenneth J Bloom; Gerald P Linette; James Stec; Edward Clark; Mark Ayers; W Fraser Symmans; Lajos Pusztai; Gabriel N Hortobagyi
HER-2/neu testing in breast cancer.
American journal of clinical pathology 2003;120 Suppl():S53-71.
2003: Jeffrey S Ross; Gary S Gray
Targeted therapy for cancer: the HER-2/neu and Herceptin story.
Clinical leadership & management review : the journal of CLMA 2003;17(6):333-40.
2003: Jeffrey S Ross; Gerald P Linette; James Stec; Edward Clark; Mark Ayers; Nick Leschly; W Fraser Symmans; Gabriel N Hortobagyi; Lajos Pusztai
Breast cancer biomarkers and molecular medicine.
Expert review of molecular diagnostics 2003;3(5):573-85.
2003: John Carlson; Andrzej Slominski; Gerald P Linette; Martin C Mihm; Jeffrey S Ross
Biomarkers in melanoma: staging, prognosis and detection of early metastases.
Expert review of molecular diagnostics 2003;3(3):303-30.
2003: Jeffrey S Ross; Karen Gray; Gary S Gray; Peter J Worland; Mark Rolfe
Anticancer antibodies.
American journal of clinical pathology 2003;119(4):472-85.
2003: John Carlson; Andrzej Slominski; Gerald P Linette; Martin C Mihm; Jeffrey S Ross
Biomarkers in melanoma: predisposition, screening and diagnosis.
Expert review of molecular diagnostics 2003;3(2):163-84.
2003: Jeffrey S Ross; Prabhjot Kaur; Christine E Sheehan; Hugh A G Fisher; Ronald A Kaufman; Bhaskar V S Kallakury
Prognostic significance of matrix metalloproteinase 2 and tissue inhibitor of metalloproteinase 2 expression in prostate cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2003;16(3):198-205.
2003: Jeffrey S Ross; Jonathan A Fletcher; Gerald P Linette; James Stec; Edward Clark; Mark Ayers; W Fraser Symmans; Lajos Pusztai; Kenneth J Bloom
The Her-2/neu gene and protein in breast cancer 2003: biomarker and target of therapy.
The oncologist 2003;8(4):307-25.
2003: Jeffrey S Ross; Geoffrey S Ginsburg
The integration of molecular diagnostics with therapeutics. Implications for drug development and pathology practice.
American journal of clinical pathology 2003;119(1):26-36.
2002: Jeffrey S Ross; Geoffrey S Ginsburg
Integration of molecular diagnostics with therapeutics: implications for drug discovery and patient care.
Expert review of molecular diagnostics 2002;2(6):531-41.
2002: Viktor N Goncharuk; Jeffrey S Ross; John Carlson
Actin-binding protein fascin expression in skin neoplasia.
Journal of cutaneous pathology 2002;29(7):430-8.
2002: Jeffrey S Ross; Christine E Sheehan; Hugh A G Fisher; Ronald A Kauffman; Eric M Dolen; Bhaskar V S Kallakury
Prognostic markers in prostate cancer.
Expert review of molecular diagnostics 2002;2(2):129-42.
2002: Jeffrey S Ross; Christine E Sheehan; Eric M Dolen; Bhaskar V S Kallakury
Morphologic and molecular prognostic markers in prostate cancer.
Advances in anatomic pathology 2002;9(2):115-28.
2002: Seth I Rosenthal; Peter L Depowski; Christine E Sheehan; Jeffrey S Ross
Comparison of HER-2/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2002;10(1):40-6.
2002: Peter L Depowski; Harry Dunn; Sheila Purdy; Jeffrey S Ross; Tipu Nazeer
Splenic marginal zone lymphoma: a case report and review of the literature.
Archives of pathology & laboratory medicine 2002;126(2):214-6.
2001: Jeffrey S Ross; Nancy Stagliano; M J Donovan; R E Breitbart; Geoffrey S Ginsburg
Atherosclerosis: a cancer of the blood vessels?
American journal of clinical pathology 2001;116 Suppl():S97-107.
2001: Nancy Stagliano; A J Carpino; Jeffrey S Ross; M Donovan
Vascular gene discovery using laser capture microdissection of human blood vessels and quantitative PCR.
Annals of the New York Academy of Sciences 2001;947():344-9.
2001: Jeffrey S Ross; Nancy Stagliano; M J Donovan; R E Breitbart; Geoffrey S Ginsburg
Atherosclerosis and cancer: common molecular pathways of disease development and progression.
Annals of the New York Academy of Sciences 2001;947():271-92; discussion 292-3.
2001: Bhaskar V S Kallakury; Christine E Sheehan; E Winn-Deen; J Oliver; Hugh A G Fisher; Ronald P Kaufman; Jeffrey S Ross
Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas.
Cancer 2001;92(11):2786-95.
2001: Bhaskar V S Kallakury; Shridevi Karikehalli; A Haholu; Christine E Sheehan; Norio Azumi; Jeffrey S Ross
Increased expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinases 1 and 2 correlate with poor prognostic variables in renal cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3113-9.
2001: Bhaskar V S Kallakury; Christine E Sheehan; Jeffrey S Ross
Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas.
Human pathology 2001;32(8):849-55.
2001: Peter L Depowski; Seth I Rosenthal; Jeffrey S Ross
Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2001;14(7):672-6.
2001: Jeffrey S Ross; Christine E Sheehan; S S Williams; John Malfetano; W M Szyfelbein; Bhaskar V S Kallakury
Decreased CD44 standard form expression correlates with prognostic variables in ovarian carcinomas.
American journal of clinical pathology 2001;116(1):122-8.
2001: John Carlson; S Amin; John Malfetano; A T Tien; B Selkin; J Hou; Viktor N Goncharuk; Vincent L Wilson; Angela Rohwedder; Robert A Ambros; Jeffrey S Ross
Concordant p53 and mdm-2 protein expression in vulvar squamous cell carcinoma and adjacent lichen sclerosus.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2001;9(2):150-63.
2001: Jeffrey S Ross; Michael B Cohen
Detecting recurrent bladder cancer: new methods and biomarkers.
Expert review of molecular diagnostics 2001;1(1):39-52.
2001: Jeffrey S Ross; Christine E Sheehan; Jonathan A Fletcher
Her-2/neu oncogene amplification determined by fluorescence in situ hybridization.
Methods in molecular medicine 2001;49():93-104.
2001: Jeffrey S Ross; Barbara J McKenna
The HER-2/neu oncogene in tumors of the gastrointestinal tract.
Cancer investigation 2001;19(5):554-68.
2000: John Carlson; K Healy; T A Tran; John Malfetano; Vincent L Wilson; Angela Rohwedder; Jeffrey S Ross
Chromosome 17 aneusomy detected by fluorescence in situ hybridization in vulvar squamous cell carcinomas and synchronous vulvar skin.
The American journal of pathology 2000;157(3):973-83.
2000: Xiao C Mu; TA Tran; Jeffrey S Ross; John Carlson
Topoisomerase II-alpha expression in melanocytic nevi and malignant melanoma.
Journal of cutaneous pathology 2000;27(5):242-8.
2000: Peter L Depowski; Seth I Rosenthal; Tom P Brien; S Stylos; R L Johnson; Jeffrey S Ross
Topoisomerase IIalpha expression in breast cancer: correlation with outcome variables.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2000;13(5):542-7.
2000: Jeffrey S Ross; Michael B Cohen
Ancillary methods for the detection of recurrent urothelial neoplasia.
Cancer 2000;90(2):75-86.
2000: TA Tran; Jeffrey S Ross; Christine E Sheehan; John Carlson
Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2000;13(4):427-32.
2000: Tom P Brien; Robert D Odze; Christine E Sheehan; Barbara J McKenna; Jeffrey S Ross
HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma.
Human pathology 2000;31(1):35-9.
1999: Jeffrey S Ross
The impact of molecular diagnostic tests on patient outcomes.
Clinics in laboratory medicine 1999;19(4):815-31, vi-vii.
1999: Peter L Depowski; G Setzen; A Chui; Peter J Koltai; J Dollar; Jeffrey S Ross
Familial occurrence of acinic cell carcinoma of the parotid gland.
Archives of pathology & laboratory medicine 1999;123(11):1118-20.
1999: Jeffrey S Ross
Financial determinants of outcomes in molecular testing.
Archives of pathology & laboratory medicine 1999;123(11):1071-5.
1999: Peter L Depowski; Tom P Brien; Christine E Sheehan; S Stylos; R L Johnson; Jeffrey S Ross
Prognostic significance of p34cdc2 cyclin-dependent kinase and MIB1 overexpression, and HER-2/neu gene amplification detected by fluorescence in situ hybridization in breast cancer.
American journal of clinical pathology 1999;112(4):459-69.
1999: TA Tran; Jeffrey S Ross; J R Boehm; John Carlson
Comparison of mitotic cyclins and cyclin-dependent kinase expression in keratoacanthoma and squamous cell carcinoma.
Journal of cutaneous pathology 1999;26(8):391-7.
1999: Jeffrey S Ross; Jonathan A Fletcher
HER-2/neu (c-erb-B2) gene and protein in breast cancer.
American journal of clinical pathology 1999;112(1 Suppl 1):S53-67.
1999: Jeffrey S Ross
Economic, regulatory, and practice issues in molecular pathology and diagnostics.
American journal of clinical pathology 1999;112(1 Suppl 1):S7-10.
1999: Xiao C Mu; Tom P Brien; Jeffrey S Ross; C V Lowry; Barbara J McKenna
Telomerase activity in benign and malignant cytologic fluids.
Cancer 1999;87(2):93-9.
1999: Jeffrey S Ross; Jonathan A Fletcher
The HER-2/neu oncogene: prognostic factor, predictive factor and target for therapy.
Seminars in cancer biology 1999;9(2):125-38.
1999: Bhaskar V S Kallakury; Christine E Sheehan; S J Rhee; Hugh A G Fisher; Ronald P Kaufman; MD Rifkin; Jeffrey S Ross
The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: a comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2.
Cancer 1999;85(7):1569-76.
1999: Jeffrey S Ross; Christine E Sheehan; Robert A Ambros; Tipu Nazeer; Timothy A Jennings; Ronald P Kaufman; Hugh A G Fisher; MD Rifkin; Bhaskar V S Kallakury
Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer.
The American journal of surgical pathology 1999;23(3):296-301.
1999: Jeffrey S Ross; F Yang; Bhaskar V S Kallakury; Christine E Sheehan; Robert A Ambros; PJ Muraca
HER-2/neu oncogene amplification by fluorescence in situ hybridization in epithelial tumors of the ovary.
American journal of clinical pathology 1999;111(3):311-6.
1998: Bhaskar V S Kallakury; Robert A Ambros; AM Hayner-Buchan; Christine E Sheehan; John Malfetano; Jeffrey S Ross
Cell proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 1998;17(4):320-6.
1998: TA Tran; Jeffrey S Ross; John Carlson; Martin C Mihm
Mitotic cyclins and cyclin-dependent kinases in melanocytic lesions.
Human pathology 1998;29(10):1085-90.
1998: Tom P Brien; Peter L Depowski; Christine E Sheehan; Jeffrey S Ross; Barbara J McKenna
Prognostic factors in gastric cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1998;11(9):870-7.
1998: Jeffrey S Ross
Molecular pathology and managed care: challenges and opportunities.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1998;7(4):189-91.
1998: TA Tran; Bhaskar V S Kallakury; Robert A Ambros; Jeffrey S Ross
Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma.
Cancer 1998;83(2):276-82.
1998: Bhaskar V S Kallakury; Christine E Sheehan; Robert A Ambros; Hugh A G Fisher; Ronald P Kaufman; PJ Muraca; Jeffrey S Ross
Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1302-9.
1998: TA Tran; Timothy A Jennings; Jeffrey S Ross; Tipu Nazeer
Pseudomyxoma ovariilike posttherapeutic alteration in prostatic adenocarcinoma: a distinctive pattern in patients receiving neoadjuvant androgen ablation therapy.
The American journal of surgical pathology 1998;22(3):347-54.
1998: R Ingle; Timothy A Jennings; M L Goodman; B Z Pilch; S Bergman; Jeffrey S Ross
CD44 expression in sinonasal inverted papillomas and associated squamous cell carcinoma.
American journal of clinical pathology 1998;109(3):309-14.
1998: D A Scalzo; Bhaskar V S Kallakury; R V Gaddipati; Christine E Sheehan; H M Keys; D Savage; Jeffrey S Ross
Cell proliferation rate by MIB-1 immunohistochemistry predicts postradiation recurrence in prostatic adenocarcinomas.
American journal of clinical pathology 1998;109(2):163-8.
1998: Jeffrey S Ross; Jonathan A Fletcher
The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.
Stem cells (Dayton, Ohio) 1998;16(6):413-28.
1997: TA Tran; Bhaskar V S Kallakury; J Carter; Barbara C Wolf; Jeffrey S Ross
Coexistence of granular cell tumor and ipsilateral infiltrating ductal carcinoma of the breast.
Southern medical journal 1997;90(11):1149-51.
1997: Bhaskar V S Kallakury; Christine E Sheehan; Robert A Ambros; Hugh A G Fisher; Ronald P Kaufman; Jeffrey S Ross
The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma.
Cancer 1997;80(4):753-63.
1997: Bhaskar V S Kallakury; Tom P Brien; C V Lowry; PJ Muraca; Hugh A G Fisher; Ronald P Kaufman; Jeffrey S Ross
Telomerase activity in human benign prostate tissue and prostatic adenocarcinomas.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1997;6(4):192-8.
1997: M W Riben; John Malfetano; Tipu Nazeer; PJ Muraca; Robert A Ambros; Jeffrey S Ross
Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(8):823-31.
1997: Jeffrey S Ross; Christine E Sheehan; AM Hayner-Buchan; Robert A Ambros; Bhaskar V S Kallakury; R Kaufman; Hugh A G Fisher; PJ Muraca
HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization.
Human pathology 1997;28(7):827-33.
1997: TA Tran; Bhaskar V S Kallakury; Christine E Sheehan; Jeffrey S Ross
Expression of CD44 standard form and variant isoforms in non-small cell lung carcinomas.
Human pathology 1997;28(7):809-14.
1997: Tom P Brien; Bhaskar V S Kallakury; C V Lowry; Robert A Ambros; PJ Muraca; John Malfetano; Jeffrey S Ross
Telomerase activity in benign endometrium and endometrial carcinoma.
Cancer research 1997;57(13):2760-4.
1997: D C Chhieng; Jeffrey S Ross; Barbara J McKenna
CD44 immunostaining of thyroid fine-needle aspirates differentiates thyroid papillary carcinoma from other lesions with nuclear grooves and inclusions.
Cancer 1997;81(3):157-62.
1997: Jeffrey S Ross; Christine E Sheehan; AM Hayner-Buchan; Robert A Ambros; Bhaskar V S Kallakury; Ronald P Kaufman; Hugh A G Fisher; MD Rifkin; PJ Muraca
Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma.
Cancer 1997;79(11):2162-70.
1997: Jeffrey S Ross
Errors and pitfalls in diagnostic cytology: new techniques applied to cytopathology.
Monographs in pathology 1997;(39):94-117.
1996: Robert A Ambros; Christine E Sheehan; Bhaskar V S Kallakury; Jeffrey S Ross; John Malfetano; E Paunovich; James J Figge
MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1996;9(12):1165-9.
1996: Joel M Kremer; H Malamood; B Maliakkal; J B Rodgers; Jeffrey S Ross; J A Cooper
Fish oil dietary supplementation for prevention of indomethacin induced gastric and small bowel toxicity in healthy volunteers.
The Journal of rheumatology 1996;23(10):1770-3.
1996: Bhaskar V S Kallakury; F Yang; James J Figge; K E Smith; S J Kausik; N J Tacy; Hugh A G Fisher; R Kaufman; H Figge; Jeffrey S Ross
Decreased levels of CD44 protein and mRNA in prostate carcinoma. Correlation with tumor grade and ploidy.
Cancer 1996;78(7):1461-9.
1996: Jeffrey S Ross
Evolving delivery systems for clinical laboratories: the Albany Medical Center Regional Laboratory Network.
Clinical laboratory management review : official publication of the Clinical Laboratory Management Association / CLMA 1996;10(5):525-8, 530-3.
1996: Jeffrey S Ross; A D del Rosario; H X Bui; Bhaskar V S Kallakury; N T Okby; James J Figge
Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1996;9(8):854-60.
1996: Jeffrey S Ross
DNA ploidy and cell cycle analysis in cancer diagnosis and prognosis.
Oncology (Williston Park, N.Y.) 1996;10(6):867-82, 887; discussion 887-90.
1996: Jeffrey S Ross; C Cheung; Christine E Sheehan; A D del Rosario; H X Bui; Hugh A G Fisher
E-cadherin cell-adhesion molecule expression as a diagnostic adjunct in urothelial cytology.
Diagnostic cytopathology 1996;14(4):310-5.
1996: Jeffrey S Ross; A D del Rosario; B Sanderson; H X Bui
Selective expression of CD44 cell-adhesion molecule in thyroid papillary carcinoma fine-needle aspirates.
Diagnostic cytopathology 1996;14(4):287-91.
1996: D C Chhieng; Jeffrey S Ross; Robert A Ambros
bcl-2 expression and the development of endometrial carcinoma.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1996;9(4):402-6.
1996: Gennady Ermak; Timothy A Jennings; L Robinson; Jeffrey S Ross; James J Figge
Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
Cancer research 1996;56(5):1037-42.
1996: Bhaskar V S Kallakury; James J Figge; B Leibovich; J Hwang; M Rifkin; R Kaufman; H L Figge; Tipu Nazeer; Jeffrey S Ross
Increased bcl-2 protein levels in prostatic adenocarcinomas are not associated with rearrangements in the 2.8 kb major breakpoint region or with p53 protein accumulation.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1996;9(1):41-7.
1995: Gennady Ermak; G Gerasimov; K Troshina; Timothy A Jennings; L Robinson; Jeffrey S Ross; James J Figge
Deregulated alternative splicing of CD44 messenger RNA transcripts in neoplastic and nonneoplastic lesions of the human thyroid.
Cancer research 1995;55(20):4594-8.
1995: Jeffrey S Ross; A D del Rosario; H L Figge; Christine E Sheehan; Hugh A G Fisher; H X Bui
E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder.
Human pathology 1995;26(9):940-4.
1995: Jeffrey S Ross; Tipu Nazeer; H L Figge; Hugh A G Fisher; M D Rifkin
Quantitative immunohistochemical determination of cathepsin D levels in prostatic carcinoma biopsies. Correlation with tumor grade, stage, PSA level, and DNA ploidy status.
American journal of clinical pathology 1995;104(1):36-41.
1995: F Ballouk; A Boguniewicz; Jeffrey S Ross; Timothy A Jennings
Image analysis quantification in hormone receptor assay of mucinous carcinoma of the breast. Comparison with biochemical analysis.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1995;17(3):151-6.
1995: Robert A Ambros; Jeffrey S Ross; Bhaskar V S Kallakury; John Malfetano; Y Kim; J Hwang; K Breese; James J Figge
p53 gene status in endometrial carcinomas showing diffuse positivity for p53 protein by immunohistochemical analysis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1995;8(4):441-5.
1995: A D del Rosario; H X Bui; S Petrocine; Christine E Sheehan; J Pastore; J Singh; Jeffrey S Ross
True synovial metaplasia of breast implant capsules: a light and electron microscopic study.
Ultrastructural pathology 1995;19(2):83-93.
1995: Jeffrey S Ross; A Eastman; A Mastrangelo; J E Baker; D N Kim
Effects of nonsteroidal antiinflammatory drugs on monocyte-endothelial cell interaction.
Annals of the New York Academy of Sciences 1995;748():559-61.
1995: D N Kim; A Eastman; J E Baker; A Mastrangelo; S Sethi; Jeffrey S Ross; J Schmee; W A Thomas
Fish oil, atherogenesis, and thrombogenesis.
Annals of the New York Academy of Sciences 1995;748():474-80; DISCUSSION 480-1.
1994: Bhaskar V S Kallakury; Timothy A Jennings; Jeffrey S Ross; K Breese; H L Figge; Hugh A G Fisher; James J Figge
Alteration of the p53 locus in benign hyperplastic prostatic epithelium associated with high-grade prostatic adenocarcinoma.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1994;3(4):227-32.
1994: A D del Rosario; H X Bui; J Singh; R Ginsburg; Jeffrey S Ross
Intracytoplasmic eosinophilic hyaline globules in cartilaginous neoplasms: a surgical, pathological, ultrastructural, and electron probe x-ray microanalytic study.
Human pathology 1994;25(12):1283-9.
1994: Jeffrey S Ross; H Figge; H X Bui; A D del Rosario; Timothy A Jennings; M D Rifkin; Hugh A G Fisher
Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
Cancer 1994;74(10):2811-8.
1994: F Ballouk; Jeffrey S Ross; B C Wolf
Ovarian endometriotic cysts. An analysis of cytologic atypia and DNA ploidy patterns.
American journal of clinical pathology 1994;102(4):415-9.
1994: Jeffrey S Ross; H L Figge; H X Bui; A D del Rosario; Hugh A G Fisher; Tipu Nazeer; Timothy A Jennings; R Ingle; D N Kim
E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcome.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(8):835-41.
1994: M Abdulla; H X Bui; A D del Rosario; B C Wolf; Jeffrey S Ross
Renal angiomyolipoma. DNA content and immunohistochemical study of classic and multicentric variants.
Archives of pathology & laboratory medicine 1994;118(7):735-9.
1994: Robert A Ambros; F Ballouk; John Malfetano; Jeffrey S Ross
Significance of papillary (villoglandular) differentiation in endometrioid carcinoma of the uterus.
The American journal of surgical pathology 1994;18(6):569-75.
1994: Tipu Nazeer; K Church; C Amato; Robert A Ambros; Thomas G Rosano; John Malfetano; Jeffrey S Ross
Comparative quantitative immunohistochemical and immunoradiometric determinations of cathepsin D in endometrial adenocarcinoma: predictors of tumor aggressiveness.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(4):469-74.
1994: Robert A Ambros; P A Vigna; James J Figge; Bhaskar V S Kallakury; Anthony Mastrangelo; A Y Eastman; John Malfetano; H L Figge; Jeffrey S Ross
Observations on tumor and metastatic suppressor gene status in endometrial carcinoma with particular emphasis on p53.
Cancer 1994;73(6):1686-92.
1994: M Khan; H X Bui; A del Rosario; M Abdulla; F Ballouk; Y J Sim; Jeffrey S Ross
Role of DNA content determination by image analysis in confirmation of dysplasia in Barrett's esophagus.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1994;7(2):169-74.
1994: Bhaskar V S Kallakury; James J Figge; Jeffrey S Ross; Hugh A G Fisher; H L Figge; Timothy A Jennings
Association of p53 immunoreactivity with high gleason tumor grade in prostatic adenocarcinoma.
Human pathology 1994;25(1):92-7.
1993: H X Bui; F Ballouk; A del Rosario; M Abdulla; M Khan; Timothy A Jennings; Jeffrey S Ross
Nuclear DNA content and clinical follow-up in resected pancreatic adenocarcinoma.
Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 1993;15(6):389-95.
1993: Jeffrey S Ross; Tipu Nazeer; K Church; C Amato; H Figge; M D Rifkin; Hugh A G Fisher
Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis.
Cancer 1993;72(10):3020-8.
1993: A D Del Rosario; H X Bui; M Abdulla; Jeffrey S Ross
Sulfur-rich prostatic intraluminal crystalloids: a surgical pathologic and electron probe x-ray microanalytic study.
Human pathology 1993;24(11):1159-67.
1993: H X Bui; C Y Lee; A del Rosario; M Abdulla; F Ballouk; M Khan; Christine E Sheehan; Jeffrey S Ross
Histologic and ultrastructural features of experimental duodenal ulcers in Sprague-Dawley rats.
Experimental and molecular pathology 1993;59(2):136-54.
1993: D N Kim; J Schmee; J E Baker; G M Lunden; Christine E Sheehan; C S Lee; A Eastman; O Solis; Jeffrey S Ross; W A Thomas
Dietary fish oil reduces microthrombi over atherosclerotic lesions in hyperlipidemic swine even in the absence of plasma cholesterol reduction.
Experimental and molecular pathology 1993;59(2):122-35.
1993: F Ballouk; Robert A Ambros; John Malfetano; Jeffrey S Ross
Evaluation of prognostic indicators in squamous carcinoma of the vulva including nuclear DNA content.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1993;6(3):371-5.
1993: Bhaskar V S Kallakury; H X Bui; A delRosario; J Wallace; O G Solis; Jeffrey S Ross
Primary gastric adenosarcoma.
Archives of pathology & laboratory medicine 1993;117(3):299-301.
1993: E Weinberg; S Hoisington; A Y Eastman; D K Rice; John Malfetano; Jeffrey S Ross
Uterine cervical lymphoepithelial-like carcinoma. Absence of Epstein-Barr virus genomes.
American journal of clinical pathology 1993;99(2):195-9.
1992: Jeffrey S Ross; H X Bui; A del Rosario; H Sonbati; M George; C Y Lee
Helicobacter pylori. Its role in the pathogenesis of peptic ulcer disease in a new animal model.
The American journal of pathology 1992;141(3):721-7.
1992: Tipu Nazeer; John Malfetano; Thomas G Rosano; Jeffrey S Ross
Correlation of tumor cytosol cathepsin D with differentiation and invasiveness of endometrial adenocarcinoma.
American journal of clinical pathology 1992;97(6):764-9.
1992: J D Veloso; O G Solis; J H Barada; Hugh A G Fisher; Jeffrey S Ross
DNA ploidy of oncocytic-granular renal cell carcinomas and renal oncocytomas by image analysis.
Archives of pathology & laboratory medicine 1992;116(2):154-8.
1992: Jeffrey S Ross; A Del Rosario; H X Bui; H Sonbati; O Solis
Primary hepatic leiomyosarcoma in a child with the acquired immunodeficiency syndrome.
Human pathology 1992;23(1):69-72.
1991: H X Bui; A del Rosario; H Sonbati; C Y Lee; M George; Jeffrey S Ross
Helicobacter pylori affects the quality of experimental gastric ulcer healing in a new animal model.
Experimental and molecular pathology 1991;55(3):261-8.
1991: James J Figge; G Bakst; D Weisheit; O Solis; Jeffrey S Ross
Image analysis quantitation of immunoreactive retinoblastoma protein in human thyroid neoplasms with a streptavidin-biotin-peroxidase staining technique.
The American journal of pathology 1991;139(6):1213-9.
1991: Tipu Nazeer; J H Barada; Hugh A G Fisher; Jeffrey S Ross
Prostatic carcinosarcoma: case report and review of literature.
The Journal of urology 1991;146(5):1370-3.
1991: O G Solis; H X Bui; J H Malfetano; Jeffrey S Ross
Extragenital primary mixed malignant mesodermal tumor.
Gynecologic oncology 1991;43(2):182-5.
1991: D N Kim; J Schmee; C S Lee; O Solis; Jeffrey S Ross; W A Thomas
Reductions in serum thromboxane, prostacyclin, and leukotriene B4 levels in swine fed a fish oil supplement to an atherogenic diet.
Experimental and molecular pathology 1991;55(1):1-12.
1991: S A Horner; Hugh A G Fisher; J H Barada; A Y Eastman; J Migliozzi; Jeffrey S Ross
Verrucous carcinoma of the bladder.
The Journal of urology 1991;145(6):1261-3.